Search results for "INFECTIONS"

showing 10 items of 2671 documents

Facial masks in children: the position statement of the Italian pediatric society

2020

AbstractFacial masks may be one of the most cost-effective strategies to prevent the diffusion of COVID 19 infection. Nevertheless, fake news are spreading, alerting parents on dangerous side effects in children, such as hypercapnia, hypoxia, gut dysbiosis and immune system weakness. Aim of the Italian Pediatric Society statement is to face misconception towards the use of face masks and to spread scientific trustable information.

Position statementWeakness2019-20 coronavirus outbreakmedicine.medical_specialtyConsensusCoronavirus disease 2019 (COVID-19)Pneumonia ViralFake newBetacoronavirus03 medical and health sciences0302 clinical medicineFacial mask030225 pediatricsDisease Transmission InfectiousmedicineHumansInfection control030212 general & internal medicinePsychiatryChildPandemicsChildrenCOVIDInfection ControlMaskPandemicBetacoronaviruSARS-CoV-2business.industryCoronavirus InfectionMaskslcsh:RJ1-570COVID-19lcsh:PediatricsEquipment DesignSettore MED/38Face masksDisease Transmission InfectiouFake newsCommentaryGut dysbiosisFake newsmedicine.symptomCoronavirus InfectionsbusinessHumanItalian Journal of Pediatrics
researchProduct

Manejo perioperatorio de pacientes con sospecha o infección grave por coronavirus SARS-CoV-2 programados para implante de dispositivos electrónicos p…

2020

Resumen La infeccion por SARS-CoV-2 ha evolucionado hasta convertirse progresivamente en una pandemia declarada por la Organizacion Mundial de la Salud (OMS) que ha obligado a las organizaciones de salud a nivel mundial, regional y local a adoptar una serie de medidas para hacer frente al COVID-19 e intentar disminuir su impacto, no solo en el ambito social sino tambien en el ambito sanitario, modificandose las pautas de actuacion en los servicios de salud. Dentro de estas recomendaciones que incluyen las Unidades de Tratamiento del Dolor, los pacientes con sospecha o infeccion confirmada por SARS-CoV-2 pueden encontrase en situacion de espera para intervencion no demorable para implante o …

Postoperative CareSARS-CoV-2business.industryPneumonia ViralCOVID-19Cancer PainCritical Care and Intensive Care MedicinePerioperative CareArtículo EspecialBetacoronavirusWearable Electronic Devices03 medical and health sciences0302 clinical medicineAnesthesiology and Pain MedicineHumansMedicine030212 general & internal medicineChronic PainCoronavirus InfectionsbusinessPandemicsHumanities030217 neurology & neurosurgeryRevista Española de Anestesiología y Reanimación
researchProduct

A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates

2020

A proof-of-concept study shows the generation of an immunogenic hexavalent Coxsackie B virus vaccine that prevents disease.

PrimatesImmunologynuoruustyypin diabetesrokotteetvasta-aineetSciAdv r-articlesCoxsackievirus Infectionscomplex mixturesEnterovirus B HumanenteroviruksetMiceMyocarditisVirologyAnimalsimmuniteettiHealth and MedicineVaccines Combinedkoe-eläinmallitResearch ArticlesResearch Article
researchProduct

Definition of criteria and indicators for the prevention of Healthcare-Associated Infections (HAIs) in hospitals for the purposes of Italian institut…

2017

Background. Healthcare-associated infections (HAIs) are an important issue in terms of quality of care. HAIs impact patient safety by contributing to higher rates of preventable mortality and prolonged hospita- lizations. In Italy, analysis of the currently available accreditation systems shows a substantial heteroge- neity of approaches for the prevention and surveillance of HAIs in hospitals. The aim of the present study is to develop and propose the use of a synthetic assessment tool that could be implemented homogenously throughout the nation. Methods. An analysis of nine international and of the 21 Italian regional accreditation systems was conducted in order to identify requirements a…

Process Assessment (Health Care)Cross InfectionProcess Assessment Health CareEnvironmental and Occupational HealthOutcome indicatorsProcess AssessmentHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoring; Public Health Environmental and Occupational Health; Infectious DiseasesSettore MED/42 - Igiene Generale E ApplicataHospitalsAccreditationHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoring; Cross Infection; Hospitals; Humans; Italy; Accreditation; Process Assessment (Health Care)Health CareHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoringInstitutional accreditationPatient safetyHealthcare-Associated Infections (HAIs); Institutional accreditation; Outcome indicators; Patient safety; Performance monitoring; Cross Infection; Hospitals; Humans; Italy; Accreditation; Process Assessment Health CareInfectious DiseasesHealthcare-Associated Infections (HAIs) Patient safety Institutional accreditation Performance monitoring Outcome indicatorsItalySettore MED/33 - Malattie Apparato LocomotoreHumansOutcome indicatorPublic HealthPerformance monitoringHealthcare-Associated Infections (HAIs)
researchProduct

Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights

2020

The current coronavirus disease 2019 (COVID-19) pandemic has led the scientific community to breach new frontiers in the understanding of human physiology and disease pathogenesis. It has been hypothesized that the human dipeptidyl peptidase 4 (DPP4) enzyme receptor may be a functional target for the spike proteins of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Since DPP4-inhibitors are currently used for the treatment of patients with type-2 diabetes (T2DM), there is currently high interest in the possibility that these agents, or incretin-based therapies (IBTs) in general, may be of benefit against the new coronavirus infection. Diabetes is associated with increased COV…

Prognostic variableCoronavirus disease 2019 (COVID-19)Pneumonia ViralIncretin030209 endocrinology & metabolism030204 cardiovascular system & hematologymedicine.disease_causeBioinformaticsIncretinsSeverity of Illness IndexGlucagon-Like Peptide-1 ReceptorBetacoronavirus03 medical and health sciences0302 clinical medicineDiabetes mellitusPandemicSeverity of illnessHumansHypoglycemic AgentsMedicinePharmacology (medical)PandemicsDipeptidyl peptidase-4CoronavirusPharmacologyDipeptidyl-Peptidase IV InhibitorsSARS-CoV-2business.industryCOVID-19medicine.diseaseDiabetes Mellitus Type 2Inflammation MediatorsCoronavirus InfectionsCardiology and Cardiovascular Medicinebusinessdiabetes DPP4 GLP1 incretins Betacoronavirus COVID-19 Coronavirus Infections Diabetes Mellitus Type 2 Dipeptidyl-Peptidase IV Inhibitors Glucagon-Like Peptide-1 Receptor Humans Hypoglycemic Agents Incretins Inflammation Mediators Pandemics Pneumonia Viral SARS-CoV-2 Severity of Illness Index
researchProduct

Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.

2013

Human parvovirus B19 (B19V) from the erythrovirus genus is known to be a pathogenic virus in humans. Prevalence of B19V infection has been reported worldwide in all seasons, with a high incidence in the spring. B19V is responsible for erythema infectiosum (fifth disease) commonly seen in children. Its other clinical presentations include arthralgia, arthritis, transient aplastic crisis, chronic anemia, congenital anemia, and hydrops fetalis. In addition, B19V infection has been reported to trigger autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. However, the mechanisms of B19V participation in autoimmunity are not fully understood. B19V induced chronic dise…

Programmed cell deathScienceAntigen-Presenting CellsArthritisApoptosisAutoimmunitySpodopteraViral Nonstructural ProteinsBiologymedicine.disease_causeAutoantigensVirusautoimmuniteettiImmune toleranceAutoimmunityParvoviridae InfectionsPathogenesis03 medical and health sciences0302 clinical medicineImmune systemPhagocytosisImmune ToleranceParvovirus B19 HumanSf9 CellsHuman Parvovirus B19medicineta319AnimalsHumansAntigen-presenting cellself-antigens030304 developmental biology0303 health sciencesMultidisciplinaryQta1182RHep G2 CellsFlow Cytometrymedicine.diseaseVirology3. Good healthImmunologyMicroscopy Electron ScanningMedicineResearch Article030215 immunologyPLoS ONE
researchProduct

Interferons increase cell resistance to Staphylococcal alpha-toxin.

2007

ABSTRACTMany bacterial pathogens, includingStaphylococcus aureus, use a variety of pore-forming toxins as important virulence factors. Staphylococcal alpha-toxin, a prototype β-barrel pore-forming toxin, triggers the release of proinflammatory mediators and induces primarily necrotic death in susceptible cells. However, whether host factors released in response to staphylococcal infections may increase cell resistance to alpha-toxin is not known. Here we show that prior exposure to interferons (IFNs) prevents alpha-toxin-induced membrane permeabilization, the depletion of ATP, and cell death. Moreover, pretreatment with IFN-α decreases alpha-toxin-induced secretion of interleukin 1β (IL-1β)…

Programmed cell deathStaphylococcus aureusCell Membrane Permeabilitymedicine.medical_treatmentImmunologyBacterial ToxinsInterleukin-1betaBiologyStaphylococcal infectionsMicrobiologyProinflammatory cytokineMicrobiologyCell LineHemolysin ProteinsAdenosine TriphosphateInterferonmedicineHumansSecretionCell DeathKinaseEpithelial CellsBacterial Infectionsmedicine.diseaseInfectious DiseasesCytokineProtein BiosynthesisParasitologyTumor necrosis factor alphaInterferonsFatty Acid Synthasesmedicine.drugInfection and immunity
researchProduct

The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem…

2019

Highlights • Rapid detection methods used as first diagnostic test for CARVs may delayed the start of antiviral therapy in a significant number of influenza and RSV cases. • Syndromic multiplex RT-PCR-based prospective clinical CARV survey in allo-HCT recipients translates into a lower mortality rate as compared to standard clinical practice based on RSV and influenza virus rapid detection test. • We found that donor/recipient HLA mismatch, CARV LRTD and high-risk ISI were also associated with higher mortality.

Prospective respiratory virus surveillance program0301 basic medicineMicrobiology (medical)medicine.medical_specialtymedicine.medical_treatment030106 microbiologyHematopoietic stem cell transplantationRespiratory syncytial virusArticleParainfluenza virus03 medical and health sciences0302 clinical medicineStudy reportCommunity-acquired respiratory virusInternal medicinemedicineHumansProspective Studies030212 general & internal medicineStage (cooking)Prospective cohort studyRespiratory Tract InfectionsRetrospective Studiesbusiness.industryHematopoietic Stem Cell TransplantationRetrospective cohort studyInfluenzaInfectious Diseasesmedicine.anatomical_structureRespiratory virus infectionVirusesAllogeneic hematopoietic stem cell transplantationRespiratory virusbusinessLower mortalityImmunodeficiency score indexRespiratory tractJournal of Infection
researchProduct

Structural analysis of Borrelia burgdorferi periplasmic lipoprotein BB0365 involved in Lyme disease infection.

2019

The periplasmic lipoprotein BB0365 of the Lyme disease agent Borrelia burgdorferi is expressed throughout mammalian infection and is essential for all phases of Lyme disease infection; its function, however, remains unknown. In the current study, our structural analysis of BB0365 revealed the same structural fold as that found in the NqrC and RnfG subunits of the NADH:quinone and ferredoxin:NAD+ sodium-translocating oxidoreductase complexes, which points to a potential role for BB0365 as a component of the sodium pump. Additionally, BB0365 coordinated Zn2+ by the His51, His55, His140 residues, and the Zn2+ -binding site indicates that BB0365 could act as a potential metalloenzyme; therefore…

Protein FoldingProtein ConformationLipoproteinsBiophysicsBiochemistryMicrobiology03 medical and health sciencesLyme diseaseBacterial ProteinsStructural BiologyOxidoreductaseGeneticsmedicineHumansBinding siteBorrelia burgdorferiMolecular BiologyFerredoxin030304 developmental biologychemistry.chemical_classification0303 health sciencesLyme DiseaseBinding SitesbiologyChemistry030302 biochemistry & molecular biologyCell BiologyPeriplasmic spacebacterial infections and mycosesmedicine.diseasebiology.organism_classificationZincMembrane proteinBorrelia burgdorferiPeriplasmbacteriaNAD+ kinaseSodium-Potassium-Exchanging ATPaseFEBS lettersReferences
researchProduct

Targeting SARS-CoV-2 RBD Interface: a Supervised Computational Data-Driven Approach to Identify Potential Modulators

2020

Coronavirus disease 2019 (COVID-19) has spread out as a pandemic threat affecting over 2 million people. The infectious process initiates via binding of SARS-CoV-2 Spike (S) glycoprotein to host angiotensin-converting enzyme 2 (ACE2). The interaction is mediated by the receptor-binding domain (RBD) of S glycoprotein, promoting host receptor recognition and binding to ACE2 peptidase domain (PD), thus representing a promising target for therapeutic intervention. Herein, we present a computational study aimed at identifying small molecules potentially able to target RBD. Although targeting PPI remains a challenge in drug discovery, our investigation highlights that interaction between SARS-CoV…

Protein domainPneumonia ViralDruggabilityDrug Evaluation Preclinicalprotein-protein interactionsComputational biologyBiologyMolecular Dynamics SimulationPeptidyl-Dipeptidase AMolecular dynamics01 natural sciencesBiochemistryMolecular Docking SimulationAntiviral Agentsdockingmolecular dynamicProtein–protein interactionSmall Molecule LibrariesBetacoronavirusProtein DomainsDrug DiscoveryHumansGeneral Pharmacology Toxicology and PharmaceuticsPandemicsPharmacologyFull Paperpharmacophore010405 organic chemistryDrug discoverySARS-CoV-2Organic ChemistryCOVID-19Small molecule0104 chemical sciencesProtein-Protein InteractionMolecular Docking Simulation010404 medicinal & biomolecular chemistryDocking (molecular)Spike Glycoprotein CoronavirusdockingMolecular MedicineAngiotensin-Converting Enzyme 2PharmacophoreCoronavirus InfectionsProtein Binding
researchProduct